Endospore-forming bacteria are ubiquitous, and their endospores can be present in food, in domestic animals, and on contaminated surfaces. Many spore-forming bacteria have been used in biotechnological applications, while others are human pathogens responsible for a wide range of critical clinical infections. Due to their resistant properties, it is challenging to eliminate spores and avoid the reactivation of latent spores that may lead to active infections. Furthermore, endospores play an essential role in the survival, transmission, and pathogenesis of some harmful strains that put human and animal health at risk. Thus, different methods have been applied for their eradication. Nevertheless, natural products are still a significant source for discovering and developing new antibiotics. Moreover, targeting the spore for clinical pathogens such as Clostridioides difficile is essential to disease prevention and therapeutics. These strategies could directly aim at the structural components of the spore or their germination process. This work summarizes the current advances in upcoming strategies and the development of natural products against endospores. This review also intends to highlight future perspectives in research and applications.
Antimicrobial resistance (AMR) is a complex issue requiring specific, multi-sectoral measures to slow its spread. When people are exposed to antimicrobial agents, it can cause resistant bacteria to increase. This means that the use, misuse, and excessive use of antimicrobial agents exert selective pressure on bacteria, which can lead to the development of "silent" reservoirs of antimicrobial resistance genes. These genes can later be mobilized into pathogenic bacteria and contribute to the spread of AMR. Many socioeconomic and environmental factors influence the transmission and dissemination of resistance genes, such as the quality of healthcare systems, water sanitation, hygiene infrastructure, and pollution. The sporobiota is an essential part of the gut microbiota that plays a role in maintaining gut homeostasis. However, because spores are highly transmissible and can spread easily, they can be a vector for AMR. The sporobiota resistome, particularly the mobile resistome, is important for tracking, managing, and limiting the spread of antimicrobial resistance genes among pathogenic and commensal bacterial species.
Fungi recovered from human fecal samples represent an understudied component of the gastrointestinal microbiome, yet fungi can play important roles in health and disease, particularly in hospitalized and immunocompromised patients. Here, we report the culture-based characterization of fungi isolated from fecal samples of 39 hospitalized patients with nosocomial diarrhea in Mexico City. Fungal growth was observed in approximately 40% of samples, yielding 26 isolates: 20 yeasts and 6 filamentous fungi. The predominant genera were Candida (mainly C. albicans) and Rhodotorula, with less common species including Nakaseomyces glabratus, Lodderomyces elongisporus, and yeasts previously explored for probiotic applications, Meyerozyma and Metschnikowia spp. Among filamentous fungi, Paecilomyces variotii and multiple Penicillium species were identified. Phenotypic assays demonstrated that several yeast isolates tolerated gut-associated stress conditions, including elevated temperature, bile salts, and oxidative stress, while thermotolerant filamentous fungi remained viable at temperatures up to 42°C. Cell-free supernatants and organic extracts of selected thermotolerant filamentous fungi showed moderate cytotoxic activity against non-differentiated Caco-2 cells.